Form 4: Humana Executive George Renaudin II Reports Stock Transactions

George Renaudin II, President of Medicare & Medicaid at Humana Inc., reports the acquisition and disposal of Humana common stock and derivative securities.

Summary

• On September 1, 2024, George Renaudin II, President of Medicare & Medicaid at Humana Inc., reported transactions involving Humana common stock.
• These transactions included the acquisition of 1,241 shares of Humana common stock and the disposal of 303 shares at a price of $352.1398.
• The transactions also involved restricted stock units vesting on September 1, 2024.
• Following these transactions, Renaudin directly owns 10,561 shares of Humana common stock and indirectly owns 496 shares through the Humana Retirement Savings Plan.
• He also holds options to purchase 4,162 shares at $510.2425, options to purchase 6,966 shares at $367.21, and various restricted stock units.
• The disposed shares were used to cover tax liabilities related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by an executive, with no inherent positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's a standard practice for executives at publicly traded companies like Humana.

Key Dates